Conclusion | In conclusion, our study suggests a possible role of the polymorphisms CCR5-Delta32, RANTES -403, and MCP-2 Q46K in the outcome of HCV infection.;In conclusion, RANTES haplotypes might contribute to the polygenic interaction between HCV and the host immune system and could help to risk stratify patients prior to antiviral therapy.;These findings indicate that CCR5 59029 is a host genetic factor that is associated with responses to IFN therapy among Japanese patients with HuLDi00025.Conclusion1 |